RecallRadar

FDA Device recall Z-2066-2016

Choledocho-Nephroscope Intended to provide optical visualization of and therapeutic access to the Abdominal Cavity

On 2016-07-06 the FDA classified a Class II recall of Choledocho-Nephroscope Intended to provide optical visualization of and therapeutic access to the Abdominal Cavity by Pentax Medical, citing pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2066-2016
ClassificationClass II
Statusterminated
Initiated2016-04-06
Published2016-07-06
Last updated2026-09-13 11:54 UTC
CompanyPentax Medical
DistributionUS

Product

Choledocho-Nephroscope Intended to provide optical visualization of and therapeutic access to the Abdominal Cavity. This anatomy includes, but is not restricted to, the organs, tissues and subsystems: Biliary tree with access to the Common bile Duct, Hepatic Duct, Cystic Duct, Kidney, Renal Cavity and Renal Calyces. The instrument is introduced via percutaneous cut when indications consistent with the need for procedure are observed in adult and pediatric patient populations.

Reason

Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.

Identifiers

code_infoModel #'s ECN-1530 and FCN-15X

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2066-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.